
House Committee Probes Pharmaceutical Companies Over China Drug Trials
A House committee has launched an investigation into several pharmaceutical companies, including Eli Lilly, Bristol, Merck, and AbbVie, regarding their clinical trials in China, particularly those tied to military-linked hospitals and facilities in Xinjiang, citing biotech risks.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)Sources
Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals
House committee launches investigation into Eli Lilly's China clinical trials at military hospitals and Xinjiang facilities, citing biotech risks.
Read full article →Bristol, Merck, AbbVie face House committee probe over China trials
Read full article →Coverage Timeline
Related Stories
Captain and Crew Arrested After Cyprus Ferry Capsizes, Killing 8
18m ago

Deadly Floods Sweep Through Nepal, Prompting International Aid Response
31m ago

Ukraine’s Former Defence Minister Seeks US Investment for Defense Tech Fund
51m ago
Ukrainian Defence Minister Promises Clear War Plan to Unlock International Funding
58m ago